If you are searching for new migraine medication names, you are probably trying to understand which newer treatments are available and what each one is designed to do. Migraine treatment has expanded considerably, particularly with CGRP-targeting medicines and newer acute options.

This guide explains important medication names, their general roles, delivery methods, and how newer treatments differ from older approaches. Drug availability and approved uses vary by country, so always verify the current label and discuss treatment choices with a healthcare professional.

New Migraine Medication Names for Acute Attacks

Acute medicines are taken when a migraine begins, with newer options offering alternatives when traditional treatments are unsuitable or ineffective.

1. Zavegepant — a CGRP receptor antagonist used for acute migraine treatment.
2. Zavzpret — the brand name for zavegepant nasal spray.
3. Ubrogepant — an oral CGRP receptor antagonist for acute migraine.
4. Ubrelvy — the brand name for ubrogepant.
5. Rimegepant — a CGRP-targeting medicine used for acute treatment and prevention.
6. Nurtec ODT — the brand name for rimegepant.
7. Lasmiditan — a serotonin 5-HT1F receptor agonist for acute migraine.
8. Reyvow — the brand name for lasmiditan.
9. Rizatriptan — a triptan used to treat an acute migraine attack.
10. Maxalt — a brand associated with rizatriptan.
11. Sumatriptan — an established triptan available in several formulations.
12. Zolmitriptan — another prescription triptan for acute migraine.
13. Eletriptan — a serotonin receptor agonist used during migraine attacks.
14. Almotriptan — an oral triptan included among FDA-approved acute treatments.
15. Symbravo — a newer combination containing meloxicam and rizatriptan.

New Migraine Medication Names Targeting CGRP

CGRP-targeting treatments represent one of the major developments in modern migraine care, with separate options for acute treatment and prevention.

1. Atogepant — an oral CGRP receptor antagonist primarily used for prevention.
2. Qulipta — the brand name for atogepant.
3. Rimegepant — a CGRP receptor antagonist with acute and preventive uses.
4. Nurtec ODT — dissolving oral formulation of rimegepant.
5. Ubrogepant — an oral CGRP antagonist for acute treatment.
6. Ubrelvy — brand name associated with ubrogepant.
7. Zavegepant — a CGRP antagonist delivered as a nasal spray.
8. Zavzpret — brand name associated with zavegepant.
9. Erenumab — a monoclonal antibody targeting the CGRP pathway.
10. Aimovig — brand name for erenumab.
11. Fremanezumab — another CGRP-targeting monoclonal antibody.
12. Ajovy — brand name for fremanezumab.
13. Galcanezumab — a CGRP monoclonal antibody used for prevention.
14. Emgality — brand name for galcanezumab.
15. Eptinezumab — an intravenous CGRP-targeting preventive treatment.

New Migraine Medication Names for Prevention

Preventive medicines are intended to reduce migraine frequency or burden rather than simply stopping an individual attack after it starts.

1. Atogepant — an oral preventive CGRP medication.
2. Qulipta — atogepant’s commonly recognized brand name.
3. Rimegepant — can be used on a preventive schedule.
4. Nurtec ODT — the marketed rimegepant product.
5. Erenumab — preventive monoclonal antibody targeting the CGRP pathway.
6. Aimovig — marketed erenumab injection.
7. Fremanezumab — preventive CGRP monoclonal antibody.
8. Ajovy — marketed fremanezumab product.
9. Galcanezumab — preventive CGRP monoclonal antibody.
10. Emgality — marketed galcanezumab product.
11. Eptinezumab — preventive CGRP antibody administered intravenously.
12. Vyepti — brand name for eptinezumab.
13. Topiramate — an established oral preventive medicine.
14. Propranolol — a beta blocker used for migraine prevention.
15. OnabotulinumtoxinA — used for prevention of chronic migraine.

New Migraine Medication Names Available as Pills

Oral treatments can be attractive to people who prefer tablets or orally dissolving medicines, although the appropriate choice depends on individual circumstances.

1. Atogepant — taken orally for migraine prevention.
2. Rimegepant — available as an orally disintegrating tablet.
3. Ubrogepant — an oral option for acute attacks.
4. Lasmiditan — an oral acute migraine medicine.
5. Rizatriptan — an oral triptan for acute migraine.
6. Sumatriptan tablets — one oral formulation of sumatriptan.
7. Zolmitriptan tablets — an oral acute treatment.
8. Eletriptan tablets — another oral triptan formulation.
9. Almotriptan tablets — an oral acute migraine option.
10. Naratriptan tablets — an oral triptan option.
11. Frovatriptan tablets — another prescription triptan.
12. Dihydroergotamine — an older migraine medicine with specific formulations.
13. Topiramate — an oral preventive medicine.
14. Divalproex sodium — an established preventive medication.
15. Symbravo tablets — oral combination treatment containing meloxicam and rizatriptan.

New Migraine Medication Names That Use Different Delivery Methods

Medication delivery can matter when nausea, vomiting, swallowing difficulty, or personal preference affects treatment.

1. Zavegepant nasal spray — delivers a CGRP antagonist through the nose.
2. Zavzpret nasal spray — branded zavegepant formulation.
3. Sumatriptan nasal spray — a non-oral triptan formulation.
4. Sumatriptan injection — injectable form for acute treatment.
5. Zolmitriptan nasal spray — another non-oral triptan option.
6. Eptinezumab infusion — intravenous preventive CGRP treatment.
7. Vyepti infusion — branded eptinezumab administration.
8. Erenumab injection — injectable preventive CGRP therapy.
9. Aimovig injection — branded erenumab.
10. Fremanezumab injection — injectable preventive therapy.
11. Ajovy injection — branded fremanezumab.
12. Galcanezumab injection — injectable preventive therapy.
13. Emgality injection — branded galcanezumab.
14. Rimegepant ODT — dissolves in the mouth rather than requiring conventional swallowing.
15. OnabotulinumtoxinA injections — administered by a healthcare professional for chronic migraine.

New Migraine Medication Names and CGRP Receptor Blockers

Gepants are a newer group of migraine medicines that work by blocking the CGRP receptor, an important pathway involved in migraine biology.

1. Ubrogepant — acute CGRP receptor antagonist.
2. Ubrelvy — branded ubrogepant.
3. Rimegepant — CGRP receptor antagonist with two approved migraine roles.
4. Nurtec ODT — branded rimegepant.
5. Atogepant — oral CGRP antagonist for prevention.
6. Qulipta — branded atogepant.
7. Zavegepant — nasal CGRP receptor antagonist.
8. Zavzpret — branded zavegepant.
9. Gepants — the broader medication class containing these small-molecule CGRP antagonists.
10. CGRP receptor antagonists — another term used for gepant medicines.
11. Acute gepants — generally refers to gepants used during attacks.
12. Preventive gepants — refers to gepants used regularly to reduce migraine frequency.
13. Oral gepants — includes several tablet-based options.
14. Nasal gepant — describes zavegepant’s delivery route.
15. CGRP pathway treatment — broader terminology covering several modern migraine approaches.

New Migraine Medication Names Compared With Triptans

Triptans remain important acute migraine treatments, while newer medicines provide additional options for some patients.

1. Sumatriptan — one of the best-known triptan medicines.
2. Rizatriptan — an oral triptan used for acute attacks.
3. Zolmitriptan — available in oral and nasal formulations.
4. Eletriptan — an oral triptan option.
5. Almotriptan — another oral triptan.
6. Naratriptan — an established acute migraine treatment.
7. Frovatriptan — another member of the triptan family.
8. Ubrogepant — newer CGRP-targeting alternative for acute treatment.
9. Rimegepant — CGRP-targeting option with acute use.
10. Zavegepant — nasal CGRP-targeting acute treatment.
11. Lasmiditan — a non-triptan serotonin-based acute treatment.
12. Symbravo — combines an NSAID with a triptan.
13. CGRP antagonists — generally act through a different pathway than triptans.
14. 5-HT1B/1D agonists — pharmacological class containing traditional triptans.
15. 5-HT1F agonist — the class containing lasmiditan.

New Migraine Medication Names for People Exploring Preventive Options

Preventive treatment becomes particularly relevant when migraine attacks are frequent, disruptive, or difficult to manage with acute medicines alone.

1. Atogepant — daily oral CGRP-targeting prevention option.
2. Rimegepant — preventive CGRP option with an established dosing schedule.
3. Erenumab — injectable preventive CGRP antibody.
4. Fremanezumab — injectable preventive CGRP antibody.
5. Galcanezumab — injectable preventive CGRP antibody.
6. Eptinezumab — intravenous preventive CGRP antibody.
7. Topiramate — established anticonvulsant used preventively.
8. Divalproex sodium — another established preventive anticonvulsant.
9. Valproic acid — related preventive medication.
10. Propranolol — beta blocker used in migraine prevention.
11. OnabotulinumtoxinA — preventive treatment for chronic migraine.
12. CGRP monoclonal antibodies — a major preventive treatment group.
13. CGRP receptor antagonists — another modern preventive category.
14. Preventive therapy — treatment intended to reduce future migraine burden.
15. Chronic migraine prevention — treatment aimed at people meeting chronic migraine criteria.

New Migraine Medication Names for Chronic Migraine

Chronic migraine requires a different prevention discussion because the pattern of headaches can be substantially more frequent.

1. OnabotulinumtoxinA — FDA-approved for chronic migraine prevention.
2. Eptinezumab — preventive CGRP monoclonal antibody.
3. Vyepti — branded eptinezumab.
4. Erenumab — preventive CGRP antibody.
5. Aimovig — branded erenumab.
6. Fremanezumab — preventive CGRP antibody.
7. Ajovy — branded fremanezumab.
8. Galcanezumab — preventive CGRP antibody.
9. Emgality — branded galcanezumab.
10. Atogepant — oral preventive CGRP antagonist.
11. Qulipta — branded atogepant.
12. Rimegepant — preventive CGRP antagonist.
13. Nurtec ODT — branded rimegepant.
14. Topiramate — established preventive option.
15. Propranolol — established preventive beta blocker.

New Migraine Medication Names and Treatment Timing

Understanding whether a medicine is designed for an attack or prevention can prevent major confusion when researching medication names.

1. Acute treatment — taken when migraine symptoms begin.
2. Preventive treatment — taken regularly to reduce future attacks.
3. Ubrogepant — acute treatment.
4. Zavegepant — acute treatment.
5. Rimegepant — acute and preventive roles.
6. Lasmiditan — acute treatment.
7. Rizatriptan — acute treatment.
8. Sumatriptan — acute treatment.
9. Atogepant — preventive treatment.
10. Erenumab — preventive treatment.
11. Fremanezumab — preventive treatment.
12. Galcanezumab — preventive treatment.
13. Eptinezumab — preventive treatment.
14. OnabotulinumtoxinA — preventive treatment for chronic migraine.
15. Symbravo — acute treatment, not prevention.

New Migraine Medication Names and Combination Treatments

Some migraine products combine established ingredients to address more than one mechanism involved in an acute attack.

1. Symbravo — combines meloxicam and rizatriptan.
2. Meloxicam — NSAID component of Symbravo.
3. Rizatriptan — triptan component of Symbravo.
4. Treximet — historical combination of sumatriptan and naproxen.
5. Sumatriptan — triptan used independently for acute migraine.
6. Naproxen — NSAID used independently in migraine treatment.
7. Acetaminophen — analgesic found in some migraine products.
8. Aspirin — NSAID component of some OTC migraine formulations.
9. Caffeine — included in certain combination headache products.
10. Excedrin Migraine — OTC combination containing acetaminophen, aspirin, and caffeine.
11. Meloxicam combinations — require attention to NSAID-related precautions.
12. Triptan combinations — combine a triptan with another analgesic.
13. Fixed-dose combinations — deliver specified ingredients in one product.
14. Single-tablet treatment — can simplify administration during an acute attack.
15. Combination therapy — should be selected with medication-specific contraindications in mind.

New Migraine Medication Names and Common Research Terms

Search terminology can help readers distinguish drug names, generic ingredients, brands, and medication classes.

1. Migraine CGRP medications — broad search phrase for modern CGRP treatments.
2. New migraine drugs — general search phrase for newer therapies.
3. New migraine medicine names — often used when seeking medication lists.
4. CGRP migraine drugs — focuses on CGRP-targeting therapies.
5. Gepants for migraine — search term for CGRP receptor antagonists.
6. Migraine prevention medicines — focuses on preventive treatment.
7. Acute migraine medicines — focuses on attack treatment.
8. Migraine nasal spray — useful for non-oral treatment searches.
9. Migraine injections — commonly refers to preventive injectable treatments.
10. Migraine infusion — can refer to intravenous preventive therapy.
11. Migraine triptans — search phrase for traditional acute medicines.
12. Migraine monoclonal antibodies — search phrase for preventive CGRP antibodies.
13. Migraine medication brand names — focuses on commercial product names.
14. Migraine generic names — focuses on active ingredients.
15. FDA-approved migraine medicines — useful for checking U.S. regulatory status.

New Migraine Medication Names and Safety Questions

Medication names should never be separated from their approved uses, contraindications, interactions, and patient-specific safety considerations.

1. Symbravo — has important cardiovascular contraindications.
2. Rizatriptan — belongs to the triptan class.
3. Meloxicam — belongs to the NSAID class.
4. Lasmiditan — may cause dizziness or sedation.
5. Gepants — have their own interaction and safety considerations.
6. CGRP antibodies — have medication-specific warnings and precautions.
7. Erenumab — has specific labeling concerning constipation and blood pressure.
8. Vyepti — carries important prescribing information for preventive use.
9. Zavegepant — is intended for acute treatment, not prevention.
10. Topiramate — has important medication-specific precautions.
11. Valproate products — require careful safety consideration.
12. Triptans — may be unsuitable for some cardiovascular conditions.
13. NSAIDs — can carry gastrointestinal, cardiovascular, kidney, and other risks.
14. Drug interactions — vary considerably between migraine medicines.
15. Pregnancy considerations — should always be discussed with a healthcare professional.

New Migraine Medication Names Worth Discussing With a Doctor

A medication list is most useful when it helps you have a more informed conversation with a qualified healthcare professional.

1. Symbravo — ask whether its combination approach is appropriate.
2. Zavegepant — ask about its nasal acute-treatment role.
3. Ubrogepant — discuss oral acute CGRP treatment.
4. Rimegepant — ask about its acute and preventive uses.
5. Atogepant — discuss its preventive role.
6. Erenumab — discuss injectable preventive therapy.
7. Fremanezumab — discuss preventive CGRP antibody treatment.
8. Galcanezumab — discuss another injectable preventive option.
9. Eptinezumab — discuss intravenous preventive treatment.
10. Lasmiditan — ask about its non-triptan acute approach.
11. Sumatriptan — discuss whether a triptan remains appropriate.
12. Rizatriptan — consider its role in acute treatment.
13. Topiramate — discuss established preventive treatment.
14. Propranolol — discuss beta-blocker prevention where appropriate.
15. OnabotulinumtoxinA — ask whether chronic migraine prevention criteria apply.

New Migraine Medication Names and What May Change in the Future

Migraine treatment continues to evolve, but “new” should always mean a verified medicine or indication rather than an unapproved product name found online.

1. CGRP therapies — remain an important modern treatment category.
2. Gepants — provide small-molecule CGRP pathway options.
3. Monoclonal antibodies — provide longer-interval preventive approaches.
4. Nasal delivery — offers an alternative to swallowing tablets.
5. Combination treatments — continue pairing established mechanisms.
6. Personalized treatment — considers migraine pattern and patient factors.
7. Acute innovation — continues to expand non-traditional treatment options.
8. Preventive innovation — continues to target migraine biology more specifically.
9. Clinical trials — investigate potential future migraine therapies.
10. FDA review — determines whether new U.S. medicines receive approval.
11. Drug labeling — defines approved uses and important safety information.
12. Postmarketing surveillance — can identify emerging safety signals.
13. Generic medicines — may expand access as patents and approvals change.
14. New indications — can expand how existing medicines are used.
15. Evidence-based treatment — remains more important than simply choosing the newest name.

Frequently Asked Questions

What are some new migraine medication names?

Examples of newer migraine treatments include Symbravo, zavegepant, ubrogepant, rimegepant, and atogepant. Several CGRP monoclonal antibodies are also modern preventive options.

What is the newest migraine medicine?

In the United States, Symbravo (meloxicam and rizatriptan) received FDA approval on January 30, 2025, for acute treatment of migraine with or without aura in adults.

Are CGRP medicines new migraine medications?

CGRP-targeting medicines are considered a newer generation of migraine therapies. They include gepants such as atogepant, rimegepant, ubrogepant, and zavegepant, plus monoclonal antibodies such as erenumab, fremanezumab, galcanezumab, and eptinezumab.

Which migraine medicines are used for prevention?

Preventive options include atogepant, rimegepant, erenumab, fremanezumab, galcanezumab, eptinezumab, topiramate, propranolol, and onabotulinumtoxinA, depending on the patient’s diagnosis and circumstances.

Which newer migraine medicines treat an attack?

Ubrogepant, rimegepant, zavegepant, lasmiditan, and Symbravo are examples of acute migraine treatments. Their approved uses and safety restrictions differ.

Are newer migraine medicines automatically better?

Not necessarily. A medicine’s suitability depends on the migraine pattern, medical history, other medications, contraindications, route of administration, and whether acute or preventive treatment is needed.

Where can I verify whether a migraine medicine is FDA approved?

The FDA recommends using Drugs@FDA and official drug labeling to check approval information, indications, and prescribing details.

Can I choose a new migraine medicine based only on its name?

No. Medication names do not provide enough information to determine whether a treatment is appropriate. A healthcare professional should review the diagnosis, medical history, other medicines, and potential risks.

Conclusion

Searching for new migraine medication names can quickly become confusing because migraine treatment now includes traditional triptans, newer gepants, CGRP monoclonal antibodies, combination products, and established preventive medicines. The most important distinction is whether a medicine is intended for acute treatment or prevention. Current FDA information shows that newer options include CGRP-targeting therapies and the January 2025 approval of Symbravo for acute migraine.

Rather than choosing a medicine simply because it is newer, use the medication names as a starting point for a discussion with your healthcare professional. Always check the current official prescribing information because indications, warnings, and availability can change.